Proquility Private Wealth Partners’s Gilead Sciences GILD Stock Holding History

Proquility Private Wealth Partners’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	$1.68M	Buy	+15,019	New	+$1.55M	0.52%	53

Other funds holding GILD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Proquility Private Wealth Partners's GILD Position: Q1 2025 in Review

Proquility Private Wealth Partners opened a new position in Gilead Sciences (GILD) in Q1 2025: 15,019 shares worth $1.68M. The stake represents 0.52% of the portfolio and ranks #53 among its holdings.

2,012 funds tracked by Wall St. Rank hold GILD as of Q1 2025.

Proquility Private Wealth Partners held 15,019 shares of Gilead Sciences worth $1.68M as of Q1 2025.
Gilead Sciences was a new Proquility Private Wealth Partners position in Q1 2025.
Gilead Sciences made up 0.52% of Proquility Private Wealth Partners's portfolio in Q1 2025, its #53 holding.
2,012 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2025.

Based on Proquility Private Wealth Partners's 13F filing for Q1 2025, filed 15 May 2025.